Cargando…
Targeting Host Glycolysis as a Strategy for Antimalarial Development
Glycolysis controls cellular energy, redox balance, and biosynthesis. Antiglycolytic therapies are under investigation for treatment of obesity, cancer, aging, autoimmunity, and microbial diseases. Interrupting glycolysis is highly valued as a therapeutic strategy, because glycolytic disruption is g...
Autores principales: | Jezewski, Andrew J., Lin, Yu-Hsi, Reisz, Julie A., Culp-Hill, Rachel, Barekatain, Yasaman, Yan, Victoria C., D’Alessandro, Angelo, Muller, Florian L., Odom John, Audrey R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482815/ https://www.ncbi.nlm.nih.gov/pubmed/34604112 http://dx.doi.org/10.3389/fcimb.2021.730413 |
Ejemplares similares
-
Rolling With Host Immunity: Virulence Beyond The Glycolysis
por: Guo, Sen, et al.
Publicado: (2022) -
Imaging Flow Cytometry and Confocal Immunofluorescence Microscopy of Virus-Host Cell Interactions
por: McClelland, Ryley D., et al.
Publicado: (2021) -
Genomic Epidemiology of Antimalarial Drug Resistance in Plasmodium falciparum in Southern China
por: Huang, Fang, et al.
Publicado: (2021) -
Manipulating Eryptosis of Human Red Blood Cells: A Novel Antimalarial Strategy?
por: Boulet, Coralie, et al.
Publicado: (2018) -
Erratum: Manipulating Eryptosis of Human Red Blood Cells: A Novel Antimalarial Strategy?
Publicado: (2019)